{"id":"https://openalex.org/W7061040004","doi":null,"title":"Organic Anion-Transporting Polypeptide (OATP) Family: Contribution of Genetic Variation and Botanical Interactions to Variability in Drug Disposition and Response","display_name":"Organic Anion-Transporting Polypeptide (OATP) Family: Contribution of Genetic Variation and Botanical Interactions to Variability in Drug Disposition and Response","alternate_titles":[],"publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W7061040004"},"language":"en","primary_location":{"id":"pmh:oai:UFDC:UFE0044024_00001","doi":null,"is_oa":false,"landing_page_url":"http://ufdc.ufl.edu/UFE0044024/00001","pdf_url":null,"source":{"id":"https://openalex.org/S4306400471","display_name":"University of Florida Digital Collections (University of Florida)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I33213144","host_organization_name":"University of Florida","host_organization_lineage":["https://openalex.org/I33213144"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W7061040004"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054155802","display_name":"Melonie L. Stanton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Stanton, Melonie Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5054155802"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.8535000085830688,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.8535000085830688,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.14579999446868896,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13984","display_name":"Nutrition, Genetics, and Disease","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/organic-anion-transporting-polypeptides","display_name":"organic anion transporting polypeptides","score":0.9340000152587891},{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.7129999995231628},{"id":"https://openalex.org/keywords/green-tea-extract","display_name":"green tea extract","score":0.7269999980926514},{"id":"https://openalex.org/keywords/fexofenadine","display_name":"fexofenadine","score":0.9089999794960022},{"id":"https://openalex.org/keywords/drug-transporter-inhibition","display_name":"drug transporter inhibition","score":0.6179999709129333},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.6000000238418579},{"id":"https://openalex.org/keywords/genetic-variability-in-drug-response","display_name":"genetic variability in drug response","score":0.6050000190734863},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.9039999842643738}],"concepts":[{"id":"https://openalex.org/C2776711289","wikidata":"https://www.wikidata.org/wiki/Q415122","display_name":"Fexofenadine","level":2,"score":0.7943000197410583},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.7822999954223633},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.727400004863739},{"id":"https://openalex.org/C2776598434","wikidata":"https://www.wikidata.org/wiki/Q18035517","display_name":"SLCO1B1","level":5,"score":0.6671000123023987},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6031000018119812},{"id":"https://openalex.org/C38022665","wikidata":"https://www.wikidata.org/wiki/Q1149305","display_name":"Disposition","level":2,"score":0.5723999738693237},{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.542900025844574},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.5019999742507935},{"id":"https://openalex.org/C170734499","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenomics","level":2,"score":0.45159998536109924},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.4449000060558319},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.3801000118255615},{"id":"https://openalex.org/C68873052","wikidata":"https://www.wikidata.org/wiki/Q349856","display_name":"Genetic variation","level":3,"score":0.35510000586509705},{"id":"https://openalex.org/C89311334","wikidata":"https://www.wikidata.org/wiki/Q1124842","display_name":"Drug metabolism","level":3,"score":0.3537999987602234},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33799999952316284},{"id":"https://openalex.org/C172777353","wikidata":"https://www.wikidata.org/wiki/Q1374271","display_name":"Genetic variability","level":4,"score":0.32280001044273376},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3181000053882599},{"id":"https://openalex.org/C2776678969","wikidata":"https://www.wikidata.org/wiki/Q28209167","display_name":"Organic anion-transporting polypeptide","level":4,"score":0.3034000098705292},{"id":"https://openalex.org/C3946865","wikidata":"https://www.wikidata.org/wiki/Q5014962","display_name":"CYP2C9","level":4,"score":0.289000004529953},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2824000120162964},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.27709999680519104},{"id":"https://openalex.org/C2910466267","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug-drug interaction","level":3,"score":0.2671000063419342},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.26660001277923584},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.26660001277923584},{"id":"https://openalex.org/C2779303165","wikidata":"https://www.wikidata.org/wiki/Q417909","display_name":"Terfenadine","level":2,"score":0.266400009393692},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.2630999982357025},{"id":"https://openalex.org/C189613389","wikidata":"https://www.wikidata.org/wiki/Q70479817","display_name":"Organic cation transport proteins","level":4,"score":0.2621000111103058},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.2563000023365021}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:UFDC:UFE0044024_00001","doi":null,"is_oa":false,"landing_page_url":"http://ufdc.ufl.edu/UFE0044024/00001","pdf_url":null,"source":{"id":"https://openalex.org/S4306400471","display_name":"University of Florida Digital Collections (University of Florida)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I33213144","host_organization_name":"University of Florida","host_organization_lineage":["https://openalex.org/I33213144"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2036888384","https://openalex.org/W2115151001","https://openalex.org/W2015349672","https://openalex.org/W1963760050","https://openalex.org/W2365477483","https://openalex.org/W1783939843","https://openalex.org/W2048521506","https://openalex.org/W1982950748","https://openalex.org/W2031861312","https://openalex.org/W2411399006"],"abstract_inverted_index":{"Drug":[0],"transport":[1,214],"plays":[2],"an":[3],"important":[4],"role":[5,267],"in":[6,28,249,272],"the":[7,35,43,82,108,126,141,205,216,250,266,276],"disposition":[8,66,115],"of":[9,34,48,52,64,110,120,128,143,155,208,232,252,258,268],"many":[10],"drugs":[11,77,92],"through":[12],"effects":[13,22,127,142],"on":[14,23,73,113,135,146,212],"absorption,":[15],"distribution,":[16],"metabolism,":[17],"and":[18,67,116,131,172,193,275],"elimination.":[19],"Ultimately,":[20],"these":[21,111],"pharmacokinetics":[24],"contribute":[25],"to":[26,85,124,179,203,237,264],"variability":[27,130],"drug":[29,53,65,74,87,114,147],"response.":[30,75,117,195],"For":[31],"instance,":[32],"members":[33],"organic":[36],"anion-transporting":[37],"polypeptide":[38],"(OATP)":[39],"family,":[40],"which":[41],"facilitate":[42],"uptake":[44],"(absorption":[45],"and/or":[46],"elimination)":[47],"a":[49,61,70,132,151,199,229],"large":[50],"variety":[51],"substrates,":[54],"are":[55,78,93],"now":[56,79],"increasingly":[57],"being":[58,94],"recognized":[59,95],"as":[60,96,177],"key":[62],"determinant":[63],"can":[68],"have":[69],"critical":[71],"impact":[72,109],"Consequently,":[76],"screened":[80],"during":[81],"development":[83],"process":[84],"identify":[86],"transporter":[88],"substrates.":[89],"As":[90],"more":[91],"substrates":[97],"for":[98],"OATP":[99,217],"transport,":[100],"it":[101],"is":[102,280],"imperative":[103],"that":[104,160,222],"we":[105,139,182,197,242],"fully":[106],"understand":[107],"transporters":[112],"The":[118],"goal":[119],"this":[121],"work":[122],"was":[123],"evaluate":[125,204],"genetic":[129],"botanical":[133],"interaction":[134],"OATP-mediated":[136,213,239,260],"transport.":[137],"First,":[138],"evaluated":[140],"OATP1B1":[144,161,189],"polymorphisms":[145],"response":[148],"by":[149],"conducting":[150],"retrospective":[152],"pharmacogenetic":[153],"analysis":[154],"atorvastatin-treated":[156],"individuals.":[157],"We":[158,220],"hypothesized":[159,221],"reduced-function":[162,190],"carrier":[163,191],"status":[164,192],"would":[165,225],"be":[166,226],"associated":[167],"with":[168],"diminished":[169],"lipoprotein":[170],"reduction":[171,176],"enhanced":[173],"inflammatory":[174],"marker":[175],"compared":[178],"non-carriers.":[180],"However,":[181],"did":[183],"not":[184],"observe":[185],"any":[186],"association":[187],"between":[188],"atorvastatin":[194],"Next,":[196],"conducted":[198],"clinical":[200,278],"pharmacokinetic":[201],"study":[202],"inhibitory":[206],"effect":[207],"green":[209,233,253,269],"tea":[210,234,254,270],"extract":[211,235,255,271],"using":[215],"probe":[218],"fexofenadine.":[219],"fexofenadine":[223,246],"exposure":[224],"altered":[227],"after":[228],"single":[230],"dose":[231],"due":[236],"decreased":[238],"uptake.":[240,261],"Interestingly,":[241],"observed":[243],"significantly":[244],"lower":[245],"plasma":[247],"concentrations":[248],"presence":[251],"suggesting":[256],"inhibition":[257],"intestinal":[259],"Future":[262],"research":[263],"investigate":[265],"transporter-mediated":[273],"interactions":[274],"resulting":[277],"implications":[279],"warranted.":[281]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7061040004","counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-10-10T00:00:00"}
